Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

(2019) Richard Gray et al.   LANCET

Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts

(2019) Danijel Sikic et al.   Translational Oncology

Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer

(2018) Tiffany A. Traina et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeting the androgen receptor in triple-negative breast cancer: current perspectives

(2017) Alain Mina et al.   OncoTargets and Therapy

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)

(2016) H. Bonnefoi et al.   ANNALS OF ONCOLOGY

The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data

(2016) Ivana Bozovic-Spasojevic et al.   CLINICAL CANCER RESEARCH

ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC)

(2016) Johannes Breyer et al.   VIRCHOWS ARCHIV

Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer

(2013) A. Gucalp et al.   CLINICAL CANCER RESEARCH

Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers

(2013) Isabell Witzel et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers

(2012) Seho Park et al.   BREAST CANCER RESEARCH AND TREATMENT

Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers

(2011) S. Park et al.   ANNALS OF ONCOLOGY

Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy

(2011) Sibylle Loibl et al.   BREAST CANCER RESEARCH AND TREATMENT

Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients

(2011) K B Lundin et al.   BRITISH JOURNAL OF CANCER

Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women

(2011) R. Hu et al.   CLINICAL CANCER RESEARCH

Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups

(2011) Michael Untch et al.   JOURNAL OF CLINICAL ONCOLOGY

Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study

(2011) Laura C Collins et al.   MODERN PATHOLOGY

Expression of androgen receptor in breast cancer and its significance as a prognostic factor

(2010) Q. Yu et al.   ANNALS OF ONCOLOGY

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

(2010) Isabella Castellano et al.   BREAST CANCER RESEARCH AND TREATMENT

Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer

(2009) A. M. Gonzalez-Angulo et al.   CLINICAL CANCER RESEARCH

Intensive Dose-Dense Compared With Conventionally Scheduled Preoperative Chemotherapy for High-Risk Primary Breast Cancer

(2009) Michael Untch et al.   JOURNAL OF CLINICAL ONCOLOGY

Androgen receptor expresion in breast cancer: Relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors

(2008) Luis O Gonzalez et al.   BMC CANCER

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers

(2008) Yoshinari Ogawa et al.   International Journal of Clinical Oncology